Interventional Neurology Device Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Interventional Neurology Market Trends and the market is segmented by Product Type (Cerebral Balloon Angioplasty and Stenting Systems, Neurothrombectomy Devices, Aneurysm Coiling and Embolization Devices, Micro-catheters and Guidewires), by Application (Artery Stenosis, Ischemic Strokes, Brain Aneurysm, Vein Stenosis, and Others), and by Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Interventional Neurology Device Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Interventional Neurology Devices Market Size

Interventional Neurology Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 8.97 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Interventional Neurology Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Interventional Neurology Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Interventional Neurology Devices Market Analysis

The Interventional Neurology Devices Market is expected to register a CAGR of 8.97% during the forecast period.

COVID-19 significantly impacted people with brain-related disorders due to limitations in the diagnostic and therapeutic processes that influenced ongoing research activities. For example, according to a study published in February 2021 in PubMed, patients with severe COVID-19 demonstrated a higher D-dimer level, suggesting an altered coagulation system state. Furthermore, the ICU-admitted COVID-19 patients showed significant thrombotic complications, including acute pulmonary embolism, ischemic stroke, deep-vein thrombosis, and systemic arterial embolism. Hence, the demand for interventional neurology devices was high during the pandemic, significantly impacting the market growth. The studied market reached its pre-pandemic nature regarding demand for interventional neurology devices as COVID-19-related restrictions were eased. Moreover, the market is believed to be registering significant growth in the coming years due to post-COVID neurological complications and new product approvals and launches.

Factors such as an increase in the incidence of neurological diseases and a rise in the adoption of minimally invasive treatment will likely fuel the market growth. For instance, as per the British Epilepsy Association data published in 2022, there were about 600,000 people with epilepsy living in the UK, around one in every 100 people. Every day, 87 people are expected to be diagnosed with epilepsy. With the high number of people living with epilepsy in the country, the demand for interventional neurology devices is increasing, contributing to market growth. Similarly, according to the 2022 update from the Parkinson's Foundation, nearly one million people in the United States were living with Parkinson's disease (PD). This number is expected to rise to 1.2 million by 2030. Parkinson's is the second-most common neurodegenerative disease after Alzheimer's disease. Hence, the high prevalence of neurological disease is likely to boost the market growth.

Additionally, the recent developments in the market, such as product reimbursement, will lead to significant growth. For instance, in June 2021, Terumo France/Europe and MicroVention Europe received reimbursement for the Roadsaver carotid stent system due to the positive assessment from the French National Authority for Health (HAS), highlighting the device's therapeutic benefit. Such initiatives will boost the market. Similarly, in September 2022, Penumbra, Inc., a global healthcare company focused on innovative therapies, publicized that its RED Reperfusion Catheters secured CE Mark (Conformité Européenne) and are available in Europe. The catheters are part of the company's Penumbra System. It is a fully integrated mechanical aspiration thrombectomy system to restore blood flow in acute ischemic stroke (AIS) patients. Also, in March 2021, Innovative Cardiovascular Solutions (ICS) reported positive results from European clinical cases using the next generation of the EMBLOK Embolic Protection System in patients undergoing transcatheter aortic valve replacement (TAVR).

Therefore, due to the increase in neurology diseases and a surge in product launches and approvals, the studied market is expected to witness significant growth over the forecast period. However, the strict rules of regulatory bodies for adopting new technologies and the high cost of devices are expected to hinder the market's growth.

Interventional Neurology Devices Industry Overview

The interventional neurology devices market is fragmented in nature. The global key players are manufacturing the majority of interventional neurology devices. Market leaders with more funds for research and a better distribution system established their position in the market. The key players in the market are Abbott, B Braun SE, Medtronic, Boston Scientific Corporation, and Stryker Corporation.

Interventional Neurology Devices Market Leaders

  1. Abbott

  2. Boston Scientific Corporation

  3. Medtronic PLC

  4. Stryker Corporation

  5. B. Braun SE

  6. *Disclaimer: Major Players sorted in no particular order
Interventional Neurology Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Interventional Neurology Devices Market News

  • March 2022: India Medtronic Private Limited, a global leader in healthcare technology, launched India's first-ever dedicated registry for collecting real-world data associated with revascularization devices in acute ischemic stroke (AIS) patients.
  • February 2022: InspireMD, Inc. received approval for the Carotid Revascularization Endarterectomy or Stenting Trial (CREST-2) Investigational Device Exemption (IDE) supplement application from the United States Food and Drug Administration (FDA).

Interventional Neurology Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Neurological Disorders
    • 4.2.2 Risng Demand for Minimally Invasive Treatment
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Devices
    • 4.3.2 Stringent Regulatory Scenario
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Cerebral Balloon Angioplasty and Stenting Systems
    • 5.1.1.1 Carotid Artery Stents
    • 5.1.1.2 Embolic Protection Systems
    • 5.1.2 Neurothrombectomy Devices
    • 5.1.3 Aneurysm Coiling and Embolization Devices
    • 5.1.4 Micro-catheters
    • 5.1.5 Guidewires
  • 5.2 By Application
    • 5.2.1 Artery Stenosis
    • 5.2.2 Ischemic Strokes
    • 5.2.3 Brain Aneurysm
    • 5.2.4 Vein Stenosis
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 B. Braun SE
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Johnson & Johnson
    • 6.1.5 Medtronic
    • 6.1.6 Merit Medical Systems.
    • 6.1.7 Penumbra, Inc.
    • 6.1.8 Stryker Corporation
    • 6.1.9 Terumo Corporation
    • 6.1.10 Integer Holdings Corporation
    • 6.1.11 Canon Inc.
    • 6.1.12 MicroPort Scientific Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Interventional Neurology Devices Industry Segmentation

As per the scope of the report, the interventional neurology devices are minimally invasive image-based technologies. The procedures involving these devices are used to diagnose and treat head, neck, and spine diseases. The Interventional Neurology Devices Market is segmented by product type (cerebral balloon angioplasty and stenting systems (carotid artery stents and embolic protection systems), neuro thrombectomy devices, aneurysm coiling and embolization devices, micro-catheters and guidewires), application (artery stenosis, ischemic strokes, brain aneurysm, vein stenosis, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type Cerebral Balloon Angioplasty and Stenting Systems Carotid Artery Stents
Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Interventional Neurology Devices Market Research FAQs

What is the current Global Interventional Neurology Devices Market size?

The Global Interventional Neurology Devices Market is projected to register a CAGR of 8.97% during the forecast period (2025-2030)

Who are the key players in Global Interventional Neurology Devices Market?

Abbott, Boston Scientific Corporation, Medtronic PLC, Stryker Corporation and B. Braun SE are the major companies operating in the Global Interventional Neurology Devices Market.

Which is the fastest growing region in Global Interventional Neurology Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Interventional Neurology Devices Market?

In 2025, the North America accounts for the largest market share in Global Interventional Neurology Devices Market.

What years does this Global Interventional Neurology Devices Market cover?

The report covers the Global Interventional Neurology Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Interventional Neurology Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Interventional Neurology Devices Industry Report

Statistics for the 2025 Interventional Neurology Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Interventional Neurology Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.